We are live on ! Find out more
TOIIW

The Oncology Institute Warrant

11 hedge funds and large institutions have $479K invested in The Oncology Institute Warrant in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1111 (0)

42% less capital invested

Capital invested by funds: $821K → $479K (-$342K)

Holders
11
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
Closed
Calls
$4K
Puts
Net Calls
+$4K
Net Calls Change
-$9K

Top Sellers

No sellers this quarter

TOIIW Hedge Fund Activity: Q1 2026 in Review

11 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q1 2026, worth a combined $479K — down 42% from $821K a quarter earlier.

Fund positioning in TOIIW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was Wolverine Asset Management, adding an estimated $399.

  • 11 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $479K of The Oncology Institute Warrant stock for Q1 2026, down 42% quarter-over-quarter.
  • 0 funds opened new The Oncology Institute Warrant positions in Q1 2026 and 0 closed out.
  • The largest The Oncology Institute Warrant buyer in Q1 2026 was Wolverine Asset Management, an estimated $399 added.

Based on aggregated 13F filings for Q1 2026.